Across GLP-1 and incretin-based therapies, we are seeing outcomes beyond the scale: - fewer major cardiovascular events - kidney protection - improvements in conditions tightly linked to cardiometabolic dysfunction, including sleep apnea biology We should stop treating obesity as a cosmetic problem and start treating it like the systemic disease driver it is, across joints, heart, kidneys, and sleep
Situation 3: The maintenance-dose phenomenon
Focus on on track, portion-smart, and feel better narratives that welcome all wellness seekers
From the peptide cost calculator to comprehensive dosing protocols and reconstitution calculators , having the right resources transforms budget management from guesswork into science
On the bike, I consume 100+ grams of carbohydrates per hour
Theoretical interaction concerns include other compounds affecting c-Met signaling, cancer treatments (especially c-Met inhibitors used in oncology), and any medication affecting hepatic metabolism